Unwrap.Fund
See how VGHCX fits your portfolio →
MF · holdings as filed 2026-04-30

What's inside VGHCX?

VANGUARD HEALTH CARE FUND
Holdings
98
positions in the fund
Top 10
41%
of fund assets
Expense ratio
0.37%
net, per year
Fund size
$37B
total net assets
Top 15 holdings
1
LLYELI LILLY & CO
9.08%
2
MRKMERCK & CO. INC.
5.41%
3
AZNASTRAZENECA PLC
5.09%
4
UNHUNITEDHEALTH GROUP INC
3.92%
5
JNJJOHNSON & JOHNSON
3.45%
6
EWEDWARDS LIFESCIENCES CORP
3.21%
7
GLAXFGSK PLC
3.13%
8
ISRGINTUITIVE SURGICAL INC
2.71%
9
BSXBOSTON SCIENTIFIC CORP
2.36%
10
DHRDANAHER CORP
2.35%
11
CVSCVS HEALTH CORP
2.20%
12
ARGNFARGENX SE
2.20%
13
ABTABBOTT LABORATORIES
2.18%
14
VRTXVERTEX PHARMACEUTICALS INC
2.09%
15
CORCENCORA INC
2.08%
Sectors
1Health Care
72%
2Unclassified
14%
3Financials
6%
4Industrials
4%
5Consumer Discretionary
2%
Geography
1United States
70%
2United Kingdom
8%
3Japan
5%
4Switzerland
4%
5Netherlands
3%
6Denmark
2%
7Ireland
2%
8Belgium
2%
Hold VGHCX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.